Search

Your search keyword '"Uraki, Ryuta"' showing total 213 results

Search Constraints

Start Over You searched for: Author "Uraki, Ryuta" Remove constraint Author: "Uraki, Ryuta" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
213 results on '"Uraki, Ryuta"'

Search Results

4. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

7. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

11. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

12. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

14. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

17. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine

21. Characterization of an EG.5.1 clinical isolate in vitro and in vivo

23. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques

26. Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate

28. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

29. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

31. Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1

33. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

35. Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer

36. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

37. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB

38. In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6

39. Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75

40. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

42. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.

43. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates

44. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2

46. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

50. Characterization of H7N9 influenza A viruses isolated from humans

Catalog

Books, media, physical & digital resources